01 6Ryzodeg
02 7Tresiba
03 6Xultophy
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 210
2019 Revenue in Millions : 162
Growth (%) : 30
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 398
2019 Revenue in Millions : 359
Growth (%) : 11
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,459
2019 Revenue in Millions : 1,506
Growth (%) : -3
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 1,483
2020 Revenue in Millions : 1,435
Growth (%) : 8
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 261
2020 Revenue in Millions : 207
Growth (%) : 33
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 405
2020 Revenue in Millions : 391
Growth (%) : 9
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 410
2021 Revenue in Millions : 405
Growth (%) : 1
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 421
2021 Revenue in Millions : 261
Growth (%) : 62
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 1,364
2021 Revenue in Millions : 1,483
Growth (%) : -8
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 1,127
2022 Revenue in Millions : 1,364
Growth (%) : -17
LOOKING FOR A SUPPLIER?
